Testing for testosterone

TRT is not recommended for men “with breast or prostate cancer, a palpable prostate nodule or induration or prostate-specific antigen greater than 4 ng/mL or greater than 3 ng/mL in men at high risk for prostate cancer such as African Americans or men with first-degree relatives with prostate cancer without further urological evaluation, hematocrit >50%, untreated severe obstructive sleep apnea, severe lower urinary tract symptoms with International Prostate Symptom Score (IPSS) >19, or uncontrolled or poorly controlled heart failure.” 1

The LOINC® codes are copyright © 1994-2017, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at  https:///license/ . Additional information regarding LOINC® codes can be found at , including the LOINC Manual, which can be downloaded at /downloads/files/

Testing for testosterone

testing for testosterone


testing for testosteronetesting for testosteronetesting for testosteronetesting for testosteronetesting for testosterone